Followers

NHS rejects ketamine for depression as psychiatrists accuse NICE of mental health discrimination

NHS rejects ketamine for depression as psychiatrists accuse NICE of mental health discrimination
Spravato (pictured), a nasal spray also known as esketamine, got the green light from the European Medicines Agency in December 2019 as a fast-acting treatment for depression sufferers.

* This article was originally published here

Comments

Popular posts from this blog

Politicians are wrong about what the public want

Federal Suit Hits Soros for $10 Billion for ‘Political Meddling, Motivated Solely by Malice’

Furious Brussels tells EU states to ignore UK as huge trade deal erupts